1. Home
  2. LGVN vs JTAI Comparison

LGVN vs JTAI Comparison

Compare LGVN & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • JTAI
  • Stock Information
  • Founded
  • LGVN 2014
  • JTAI 2018
  • Country
  • LGVN United States
  • JTAI United States
  • Employees
  • LGVN N/A
  • JTAI N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • JTAI Blank Checks
  • Sector
  • LGVN Health Care
  • JTAI Finance
  • Exchange
  • LGVN Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • LGVN 31.2M
  • JTAI 9.0M
  • IPO Year
  • LGVN 2021
  • JTAI N/A
  • Fundamental
  • Price
  • LGVN $2.91
  • JTAI $0.29
  • Analyst Decision
  • LGVN Strong Buy
  • JTAI
  • Analyst Count
  • LGVN 1
  • JTAI 0
  • Target Price
  • LGVN $12.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • JTAI 393.4K
  • Earning Date
  • LGVN 08-09-2024
  • JTAI 08-15-2024
  • Dividend Yield
  • LGVN N/A
  • JTAI N/A
  • EPS Growth
  • LGVN N/A
  • JTAI N/A
  • EPS
  • LGVN N/A
  • JTAI N/A
  • Revenue
  • LGVN $978,000.00
  • JTAI $14,187,646.00
  • Revenue This Year
  • LGVN $137.24
  • JTAI $23.77
  • Revenue Next Year
  • LGVN $50.77
  • JTAI $14.43
  • P/E Ratio
  • LGVN N/A
  • JTAI N/A
  • Revenue Growth
  • LGVN N/A
  • JTAI N/A
  • 52 Week Low
  • LGVN $0.77
  • JTAI $0.25
  • 52 Week High
  • LGVN $35.60
  • JTAI $17.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 51.81
  • JTAI 34.30
  • Support Level
  • LGVN $2.90
  • JTAI $0.25
  • Resistance Level
  • LGVN $4.88
  • JTAI $0.38
  • Average True Range (ATR)
  • LGVN 0.70
  • JTAI 0.05
  • MACD
  • LGVN -0.04
  • JTAI 0.01
  • Stochastic Oscillator
  • LGVN 27.59
  • JTAI 27.98

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: